144: Filer Information

Filer CIK

0001380585

Filer CCC

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE

TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

Guardion Health Sciences, Inc.

SEC File Number

001-38861

Address of Issuer

2925 RICHMOND AVENUE
SUITE 1200
HOUSTON
TEXAS
77098

Phone

(800) 873-5141

Name of Person for Whose Account the Securities are To Be Sold

Radoff Bradley Louis

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common Stock, par value $0.001 per share

Morgan Stanley
1585 Broadway
New York � NY � 10036

217900

3593171.00

1284156

08/26/2024

NASDAQ

Common Stock, par value $0.001 per share

UBS Financial Services Inc.
1000 Harbor Blvd.
Wehawken � NJ � 07086

25100

413899.00

1284156

08/26/2024

NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common Stock, par value $0.001 per share

10/06/2022

Open Market Purchases

N/A

217900

10/06/2022

Cash

Common Stock, par value $0.001 per share

11/25/2022

Open Market Purchases

N/A

25100

11/25/2022

Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

The aggregate market value is as of market open on 08/26/2024. The number of securities outstanding is as of 07/31/2024. The 217,900 shares proposed to be sold held directly by Mr. Radoff were acquired and paid for between 10/06/2022 and 01/09/2023. The 25,100 shares proposed to be sold held directly by The Radoff Family Foundation, of which Mr. Radoff serves as director, were acquired and paid for between 11/25/2022 and 12/12/2022.

Date of Notice

08/26/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Bradley L. Radoff

144: Filer Information

Submission Contact Information

144: Issuer Information

144: Securities Information

144: Securities To Be Sold

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

SEC Form 144 filed by Guardion Health Sciences Inc.